Bionik Laboratories Corp. (BNKL) Cash flow
Market cap
$12.48
P/E ratio
| 2011/12 | 2015/12 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Depreciation & amortization | - | - | - | - | - | - | 189,730 | 102,623 | 63,167 |
| Stock-based compensation | 800 | 2 | 1 | 2 | 1 | 2 | 819,213 | - | - |
| Cash from operations | -4,250 | -4,590,387 | -6,992,313 | -7,710,862 | -9,232,411 | -9,063,554 | -4,623,886 | -4,147,287 | -3,387,314 |
| Capital expenditures | - | - | - | - | - | - | - | -12,500 | - |
| Cash from investing | - | -380,195 | -170,790 | -21,567 | -101,779 | -159,645 | - | -12,500 | -223,694 |
| Cash from financing | 23,850 | 11 | 2 | 8 | 9 | 11 | 3 | 6 | 2 |
| Free cash flow | - | - | - | - | - | - | - | ||
| FCF margin (%) | - | - | - | - | - | - | - |